Lot Release Number |
2021-05-11-0212
|
FDA Registered Product/Generic Name |
TRASTUZUMAB EMTANSINE
|
Brand Name |
KADCYLA
|
Dosage Strength |
100 mg
|
Dosage Form |
POWDER FOR CONCENTRATE FOR SFI (I.V.)
|
Registration Number |
BR-953
|
Batch/Lot Number |
B2801
|
Packaging Lot |
Packaging Lot (Box): B2801B05; (Vial): B2801
|
Product Expiration Date |
31 July 2023
|
Issuance Date |
14 May 2021
|